In a bid to boost biopharma research and development activities, the Telangana government is planning to set-up Indias first Biopharma-Hub at Genome Valley in Hyderabad.
The Biopharma-Hub to be established through Public Private Partnership (PPP) mode, will incur an estimated cost of Rs 60 crore, an official release said. It will be India’s first organised cluster for life sciences Research & Development and clean manufacturing activities.
“B-Hub will be a first of its kind initiative in the country, aimed at providing much needed support to the biopharma R&D activities, featuring a scale-up manufacturing facility, along with a turnkey incubator/lab space module at Good Laboratory Practises grade within a built-up area of 40,000 square feet,” it said.
The strategy behind the establishment of end-to-end biopharma scale-up manufacturing facility is to provide impetus to domestic companies which fare badly in comparision to foreign counterparts like Korea, China and France in terms of biopharma innovation.
Companies which are at early stage of clinical development, but lack the requisite expertise and resources to navigate the complexities associated with business planning, technology, and/or regulatory and risk assessment, can leverage B-Hub facility to help break down roadblocks and improve the likelihood of commercial success, the release said.
With Indian companies aggressively embarking on the global biosimilars opportunity, a biopharma scale-up facility will help them leapfrog in their endeavour, while reducing the time to market, Industries minister KT Rama Rao said.